Sign In
Buy QMCO
$13.97
+0.230 (+1.67%)
At Close: Jun 15, 2026
2 Top Quantum Computing Stocks to Buy in February
03:45am, Wednesday, 04'th Feb 2026
Google parent Alphabet is an AI juggernaut with a quantum computing lottery ticket. IonQ arguably ranks as the best of the quantum computing pure plays.
NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed on behalf of shareholders of Quantum Biopharma Ltd. (“Quantum” or the “Company”)
Quantum Computing Inc. Completes Acquisition of Luminar Semiconductor, Inc.
06:20pm, Monday, 02'nd Feb 2026
Transaction strengthens QCi's technology roadmap and advances QCi toward becoming a vertically integrated, domestic provider of photonics and quantum platforms HOBOKEN, N.J., Feb. 2, 2026 /PRNewswire
Quantum Stocks: February 2026 Outlook After January's Sell-Off
04:00pm, Monday, 02'nd Feb 2026
After January's sell-off, quantum stocks face a selective February, with IonQ aided by a $1.8B SkyWater deal as macro pressure lingers.
D-Wave's Big Deal, Bigger Question: Can Sales Catch Up to the Hype?
03:32pm, Monday, 02'nd Feb 2026
It has been a big year so far for D-Wave Quantum Inc. NYSE: QBTS, as the company closed on its $550-million cash and stock acquisition of Quantum Circuits in January, dramatically increasing D-Wave's
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
12:00pm, Monday, 02'nd Feb 2026
New class action for Quantum Biopharma Ltd urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 2/23/2026.
Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma Ltd. Investors
10:46am, Monday, 02'nd Feb 2026
LOS ANGELES, Feb. 02, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Quantum Biopharma Ltd. (“Quantum” or the "Company") (NASDAQ: QNTM) investors of a class action on behalf of investors th
Quantum Appoints William H. White as Chief Financial Officer
08:00am, Monday, 02'nd Feb 2026
CENTENNIAL, Colo.--(BUSINESS WIRE)--Quantum Corporation (Nasdaq: QMCO) today announced the appointment of William H. White as its Chief Financial Officer. White will lead Quantum's global finance orga
SuperQ Quantum Engages Dr. Reuter Investor Relations to Expand German and European Market Presence
07:00am, Monday, 02'nd Feb 2026
Calgary, Alberta--(Newsfile Corp. - February 2, 2026) - SuperQ Quantum Computing Inc. (CSE: QBTQ) (OTCQB: QBTQF) (FSE: 25X) ("SuperQ Quantum", "SuperQ", or the "Company"), the leading quantum orches
Vancouver, British Columbia and San Diego, California--(Newsfile Corp. - February 2, 2026) - CyberCatch Holdings, Inc. (TSXV: CYBE) (OTCQB: CYBHF) ("CyberCatch'' or the "Company"), a cybersecurity com
Where Will D-Wave Quantum Stock Be in 5 Years?
03:02pm, Sunday, 01'st Feb 2026
Analysts and corporate leaders have asserted that commercially viable quantum computers could be available by the decade's end. D-Wave Quantum is a small pure play trying to compete with massive tech
D-Wave Quantum CEO on Latest Growth & Adoption Trends
10:15am, Friday, 30'th Jan 2026
Dr. Alan Baratz, CEO of D-Wave Quantum (QBTS), joins Opening Bell with a slew of updates on the company's growth picture. He shares details of new deals, including a 2-year $10M agreement with a Fortu
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
12:00pm, Thursday, 29'th Jan 2026
New class action for Quantum Biopharma Ltd urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 2/23/2026.
NEW YORK, Jan. 29, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed on behalf of shareholders of Quantum Biopharma Ltd. ("Quantum" or the "Company") (NASDAQ: QN
Calgary, Alberta--(Newsfile Corp. - January 29, 2026) - SuperQ Quantum Computing Inc. (CSE: QBTQ) (OTCQB: QBTQF) (FSE: 25X) ("SuperQ Quantum", "SuperQ", or the "Company") is pleased to announce that
